Blood inflammation may hold clues to psychiatric diagnosis

NCT ID NCT05934474

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study investigates whether markers of inflammation in the blood could serve as diagnostic or severity biomarkers across several psychiatric conditions, including bipolar disorder, schizophrenia, and depressive episodes with psychotic features. Researchers will collect blood samples and symptom assessments from 50 adults under psychiatric care at a French hospital. The goal is to identify common inflammatory patterns that might improve diagnosis and treatment monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could point toward blood-based biomarkers to help diagnose and assess severity of certain psychiatric disorders.
What could go wrong
This is an early-stage observational study with a small sample size, so findings may not be generalizable or lead to clinical tools.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nantes University Hospital

    RECRUITING

    Nantes, 44100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.